Table 1.
Patient and tumor characteristics
| Characteristic | N (%) |
|---|---|
| Age (median years, range) | 61 (33–87) |
| Sex | |
| Male | 35 (61.4) |
| Female | 22 (38.6) |
| Performance status (Eastern Cooperative Oncology Group) | |
| 1 | 26 (45.6) |
| 2 | 21 (36.8) |
| 3 | 8 (14.0) |
| 4 | 2 (3.5) |
| Histopathology | |
| Adenocarcinoma | 52 (91.2) |
| Signet ring cell carcinoma | 5 (8.8) |
| Stage (American Joint Committee on Cancer 8th revision) | |
| IIA | 1 (1.8) |
| IIB | 2 (3.5) |
| IIIA | 2 (3.5) |
| IIIB | 2 (3.5) |
| IV | 50 (87.7) |
| Chemotherapy | |
| Before radiotherapy | 43 (75.4) |
| During radiotherapy | 10 (17.5) |
| After radiotherapy | 27 (47.4) |
| Endoscopic hemostasis therapy before radiotherapy | |
| No | 11 (19.3) |
| Yes | 46 (80.7) |
| Baseline hemoglobin (median g/dL, range) | 6.6 (3.9–9.9) |